Michael J. Fox Foundation for Parkinson's Research
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Michael J. Fox Foundation for Parkinson's Research sits in the top decile of US sponsors by registered trial count (#987 of 15,742 sponsors by registered trial count).
Michael J. Fox Foundation for Parkinson's Research: 14 sponsored US clinical trials, 5 recruiting.
Michael J. Fox Foundation for Parkinson's Research sponsors 14 registered US clinical trials on ClinicalTrials.gov, 5 of them currently recruiting, and 7 completed. 0 of these trials are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Parkinson Disease, with 7 trials.
Top-decile sponsor footprint
Michael J. Fox Foundation for Parkinson's Research ranks in the top decile of sponsors by registered trial count (#987 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
14 total, page 1 of 1
Evaluation of Tau-Pathology in Sporadic and LRRK2 Parkinson's Disease
NCT07020026
Early Longitudinal Imaging in the Parkinson's Progressive Marker Initiative (PPMI) Using (18F)AV-133 (PPMI AV-133 Prodromal Imaging)
NCT07265596
Parkinson Progression Marker Initiative Online (PPMI Online)
NCT05065060
Black and African Americans Connections to Parkinson's Disease (BLAAC PD)
NCT06719583
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
NCT04477785
Early Longitudinal Imaging in Parkinson's Progression Markers Initiative Using [¹⁸F] AV-133 and DaTscan™
NCT04507139
PPMI Tau PET Imaging
NCT04906590
FoxBioNet: ECV (Extracellular Vesicle) 004
NCT04603326
Fox BioNet Project: ECV-003
NCT03775447
Fox BioNet Project: LRRK2-002
NCT03545425
FoxBioNet Pilot Project: SAVE (Synuclein Assay Validation Effort)
NCT03170063
Systemic Synuclein Sampling Study (S4)
NCT02572713
A Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AVE8112 in Patients With Parkinson's Disease
NCT01803945
Fox Investigation for New Discovery of Biomarkers
NCT01705327
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 3 |
Therapeutic Areas
What is open in the Michael J. Fox Foundation for Parkinson's Research pipeline
5 recruiting of 14 indexed (36% open); 7 completed (50%).
Phase mix: 0 late (III/IV) vs 4 early (I/II) (early-phase heavy).
Top condition: Parkinson Disease (7 trials), 2 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Michael J. Fox Foundation for Parkinson's Research: open-pipeline peers nationwide
Peers matched on 14 registered trials and 36% open enrollment, not the therapeutic-area sidebar.
Michael J. Fox Foundation for Parkinson's Research sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 14 trials (± recruiting share)
- 3-C Institute for Social Development · 14 trials · 0% recruiting
- Abbott Medical Optics · 14 trials · 0% recruiting
- Abbott RDx Cardiometabolic · 14 trials · 0% recruiting
- Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA · 14 trials · 0% recruiting
Sponsors near 36% open enrollment (± trial volume)
- BioNTech SE · 36% recruiting · 53 trials
- Trustees of Dartmouth College · 35% recruiting · 31 trials
- Stemline Therapeutics · 35% recruiting · 17 trials
- CooperVision International Limited (CVIL) · 36% recruiting · 11 trials
Related
What to do with this Michael J. Fox Foundation for Parkinson's Research page
14 registered trials is a research-attention snapshot, not an endorsement of Michael J. Fox Foundation for Parkinson's Research or any single study.
- 5 of Michael J. Fox Foundation for Parkinson's Research's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Parkinson Disease is the condition Michael J. Fox Foundation for Parkinson's Research studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Parkinson Disease trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Michael J. Fox Foundation for Parkinson's Research pipeline card: 14 registered trials from official public datasets.Report a data error.